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AGE AND HEMORHEOLOGIC CHANGES IN STROKE
Piotr Kowal and Grazyna Hurla
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SUMMARY · Stroke is known to be most common in the elderly. Rheologic factors play an impor-
tant role in the cerebral flow regulation and distinctly correlate with the atherosclerotic process. The
aim of this study was to assess the degree to which rheologic changes were related to the age of
patients with acute cerebral ischemia. The study included 26 patients and 12 control subjects. Pa-
tients were divided into two age groups: ≥70 (n=11, mean age 77.8) and ≤60 (n=15, mean age 52.3)
years. The following hemorheologic parameters were observed: blood viscosity (BV), plasma viscos-
ity (PV), hematocrit (Htc), red cell deformability (RCD), internal erythrocyte viscosity (IEV), red
cell aggregation (RCA), and fibrinogen concentration. Hemorheologic factors were estimated dur-
ing the first 48 hours and after 3 weeks of disease onset. BV, PV, RCA, IEV and fibrinogen were
significantly elevated, whereas Htc and RCD were significantly decreased in the ≥70-year group as
compared with control subjects. Relative to the ≤60-year group, patients from the ≥70-year group
showed significantly higher values of BV, PV, IEV and RCA, and significantly lower values of RCD
and Htc. The hemorheologic profile at 3 weeks from stroke onset was similar to that recorded in the
acute phase. Results of the study indicated that hemorheologic changes in patients with cerebral is-
chemia were clearly dependent on the patient age.
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Introduction
Stroke is known to most commonly occur in the eld-
erly. Factors such as quantitative and qualitative changes
of red and white blood cells and platelets, as well as
changes in the composition of plasma have been identi-
fied as being responsible for the increase in blood viscos-
ity. Hemorheologic abnormalities occurring in patients
with cerebrovascular disease should be considered as part
of a multifactorial mechanism leading to cerebral infarc-
tion1.
Abnormal hemorheologic conditions can be favorably
influenced upon by various substances, however, there is
no simple relation between the hemorheologic profile and
clinical status of stroke patients.
The aim of the study was to assess the degree to which
rheologic changes were related to the age of patients with
acute cerebral ischemia.
Subjects and Methods
The study included 26 patients with acute cerebral is-
chemia and 12 control subjects. Patients were divided into
two age groups: ≥70 (n=11, mean age 77.8) and ≤60 (n=15,
mean age 52.3) years. Venous blood was sampled into
EDTA tubes (1 mg/ml). In acute cerebral ischemia pa-
tients, blood sampling was performed during the first 48
hours and at 3 weeks of disease onset. The following
hemorheologic parameters were observed:
· whole blood viscosity (WBV) by use of rotational
viscosimeter at a shear rate of 216.513 s-1;
· plasma viscosity (PV) by use of capillary viscosim-
eter;
· relative blood viscosity (RBV) was calculated as a
quotient of WBV and PV;
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· internal erythrocyte viscosity (IEV) was calculated
according to the equation:
IEV =
/ RBV /0.4 −1
/ RBV /0.4 x Htc
· red cell deformability (RCD) by use of the filtra-
tion method; filtration index was estimated for
whole blood and 42% of RBC suspension in sepa-
rate; and
· red cell aggregation (RCA) was estimated on the
basis of erythrocyte sedimentation rate (ESR) and
plasma viscosity value (the result was adjusted to
30% of Htc).
The following biochemical parameters were deter-
mined in all study patients and control subjects: albumin,
IgG, IgA, IgM, apolipoprotein A1 and B by use of
nephelometer (Behring), cholesterol, triglycerides, LDL
(Cobas Mira) and HDL (Abbott). The level of fibrino-
gen was determined by the method of Clauss.
Hemorheologic data are presented as mean and stan-
dard error of mean. Student’s t-test was used on statisti-
cal analysis.
Results
During the first 48 hours of the disease, significantly
higher values of the following hemorheologic parameters:
WBV (p<0.05), RBV (p<0.05), IEV (p<0.005), RCA
(p<0.005) and lower values of whole blood RCD and Htc
(p<0.05 both) were recorded in the ≥70-year group as
compared with the ≤60-year group patients (Table 1).
Comparison with the control group of subjects showed no
significant differences for the ≤60-year group, however, in
Table 1. Hemorheologic profile characterstics in two patient age groups (≥70 and ≤60 years of age) at 48 hours
from disease onset
Parameter Controls ≥70 yrs    p ≤60 yrs
WBV (cP) 3.74±0.11 5.45±0.56**** <0.05 4.19±0.20
PV (cP) 1.42±0.01 1.54±0.05**   n.s. 1.47±0.02
RBV 2.62±0.07 3.49±0.30*** <0.05 2.84±0.12
Fibrinogen (g/l) 2.85±0.12 3.72±0.27***   n.s. 3.60±0.49
Whole blood RCD (ml/min) 0.99±0.03 0.75±0.07*** <0.05 0.96±0.06
42% suspension RCD (ml/min) 1.15±0.04 0.99±0.03*   n.s. 1.11±0.06
IEV 0.70±0.03 0.89±0.05***** <0.005 0.74±0.02
RCA (mm/h) 11.19±2.0 42.05±9.43**** <0.005 15.47±1.91
Htc 0.45±0.006 0.43±0.01* <0.05 0.46±0.01
Significance vs controls: *p<0.05; **p<0.02; ***p<0.01; ****p<0.005; *****p<0.001
Table 2. Hemorheologic profile characterstics in two patient age groups (≥70 and ≤60 years of age) at 3 weeks from
disease onset
Parameter Controls    ≥70 yrs   p  ≤60 yrs
WBV (cP) 3.74±0.11 4.52±0.37*   n.s. 4.21±0.24
PV (cP) 1.42±0.01 1.55±0.03****   n.s. 1.51±0.03
RBV 2.62±0.07 2.90±0.21   n.s. 2.78±0.15
Fibrinogen (g/l) 2.85±0.12 4.00±0.47**   n.s. 3.19±0.18
Whole blood RCD (ml/min) 0.99±0.03 0.87±0.03*   n.s. 0.85±0.09
42% suspension RCD (ml/min) 1.15±0.04 1.04±0.03   n.s. 1.06±0.03
IEV 0.70±0.03 0.84±0.04*** <0.02 0.72±0.02
RCA (mm/h) 11.19±2.0 61.28±9.93**** <0.01 24.72±7.63
Htc 0.45±0.006 0.40±0.01*** <0.001 0.46±0.01
Significance vs controls: *p<0.05; **p<0.02; ***p<0.005; ****p<0.001
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the ≥70-year group the following parameters were found
to be significantly different: WBV(p<0.005), PV (p<0.02),
RBV (p<0.01), level of fibrinogen (p<0.01), whole blood
RCD (p<0.01), RCD for 42% RBC suspension (p<0.05),
IEV (p<0.001), RCA (p<0.005), and Htc (p<0.05).
At 3 weeks from the onset of disease, higher values
of IEV (p<0.01) and RCA (p<0.01) were found in the
≥70-year group as compared with the ≤60-year group
patients, whereas Htc was significantly lower (p<0.001)
in the former group (Table 2). In comparison with con-
trol subjects, a significantly higher value of PV was ob-
served in the ≤60-year group patients (p<0.05), whereas
in the ≥70-year group patients significant differences
were recorded for the following parameters: WBV
(p<0.005), PV (p<0.001), level of fibrinogen (p<0.02),
whole blood RCD (p<0.05), IEV (p<0.005), RCA
(p<0.001), and Htc (p<0.005). There were no statistically
significant differences in the hemorheologic profile be-
tween the acute and late phase of stroke in the study
groups of patients.
Comparative analysis of biochemical parameters other
than fibrinogen (Tables 3 and 4) revealed a higher level
of IgM (p<0.01) in the ≥70-year group as compared with
either ≤60-year group patients or control subjects
(p<0.01); the level of IgA was significantly higher
(p<0.01), while albumin, apolipoprotein A1 and HDL
were significantly lower in the ≥70-year group patients as
compared with controls (p<0.02, p<0.05 and p<0.05, re-
spectively).
Discussion
A strong relationship was demonstrated between the
hemorheologic changes and age of stroke patients. It is no
surprise, because hemorheologic disturbances increase
with arteriosclerotic lesions of the cerebral vessels. The fre-
quency of whole blood viscosity parameters has been
found to increase with the degree of arteriosclerotic le-
sion2. It has also been observed that some hemorheologic
changes seem to have a specific character in relation to a
certain vascular pathology3.
Monitoring of the hemorheologic properties after
acute cerebral ischemia reveals a persistent profile of fac-
tors such as blood and plasma viscosity, red cell aggrega-
tion, and erythrocyte deformability. Red cell aggregation
increased in the ≥70-year group of stroke patients during
3 weeks from the onset of disease, predominantly due to
the role of biochemical factors other than fibrinogen and
properties immanently associated with red cells.
The possible effect of hemorheologic changes in eld-
erly stroke patients should be expected to involve a more
Table 3. Protein factors in two stroke patient age groups (≥70 and ≤60 years of age)
Parameter    Controls    ≥70 yrs    p ≤60 yrs
Albumin (mg%) 4273.33±94.10 3896.25±95.72*   n.s. 4220.0±219.64
γ Globulin (mg%) 1758.08±120.79 1834.81±93.81   n.s. 1757.62(100.53
IgG (mg%) 1299.25±87.74 1275.93±51.25   n.s. 1178.50±79.98
IgA (mg%) 235.83±28.96 440.0±55.16**   n.s. 360.87±33.98*
IgM (mg%) 223.0±31.79 118.87±8.99** <0.01 218.25±28.33
Albumin/γ globulin 2.55±0.18 2.21±0.13   n.s. 2.47±0.23
Significance vs controls: *p<0.02; **p<0.01
Table 4. Lipid factors in two stroke patient age groups (≥70 and ≥60 years of age)
Parameter    Controls      ≥70 yrs  p ≤60 yrs
Apolipoprotein A1 (mg%) 168.0±6.64 145.86±6.42* n.s. 144.72±9.99
Apolipoprotein B (mg%) 145.33±11.44 128.50±7.97 n.s. 130.37±11.15
Cholesterol (mg%) 227.25±11.08 199.94±11.09 n.s. 215.37±17.01
Triglycerides (mg%) 169.66±33.49 169.47±19.37 n.s. 137.0±16.24
HDL (mg%) 58.33±5.30 46.0±2.64* n.s. 46.50±3.86
LDL (mg%) 134.91±12.29 120.52±10.27 n.s. 142.62±12.73
Significance vs controls: *p<0.05
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severe impairment of cerebral microcirculation than in
younger patients. The lower level of Htc observed in the
≥70-year group patients suggests the existence of a cer-
tain mechanism of feedback, initiated by the high value
of blood viscosity.
Conclusion
Hemorheologic changes observed in patients with
brain ischemia are clearly dependent on the patient age,
and their role in the cerebral blood flow regulation should
be considered in relation to a certain vascular pathology.
Saæetak
STAROSNA DOB I HEMOREOLO©KE PROMJENE KOD MOÆDANOG UDARA
P. Kowal i G. Hurla
Poznato je da su starije osobe najËe¹Êe ærtve moædanog udara. Reolo¹ki Ëimbenici imaju vaænu ulogu u regulaciji moædanoga
krvotoka i jasno koreliraju s aterosklerotskim procesom. Cilj ovoga ispitivanja bio je utvrditi do kojeg su stupnja reolo¹ke
promjene povezane s dobi bolesnika s akutnom moædanog ishemijom. Ispitivanje je provedeno u 26 bolesnika i 12 kontrolnih
osoba. Bolesnici su bili podijeljeni u dvije dobne skupine: ≥70 godina (n=11, srednja dob 77,8) i ≤60 godina (n=15, srednja
dob 52,3) godina. Ispitivani su sljedeÊi hemoreolo¹ki parametri: viskoznost krvi (VK), viskoznost plazme (VP), hematokrit
(Htc), deformabilnost crvenih stanica (DCS), unutarnja viskoznost eritrocita (UVE), agregacija crvenih stanica (ACS) i
koncentracija fibrinogena. Hemoreolo¹ki Ëimbenici odreðeni su u prvih 48 sati te 3 tjedna nakon nastupa bolesti. VK, VP,
UVE, ACS i razina fibrinogena bili su znaËajno povi¹eni, a Htc i DCS znaËajno niæi u skupini bolesnika u dobi od ≥70 godina
u usporedbi s kontrolnim osobama. U odnosu na skupinu bolesnika u dobi od ≤60 godina, stariji su bolesnici (≥70 godina)
imali znaËajno vi¹e vrijednosti VK, VP, UVE i ACS, dok su Htc i DCS bili znaËajno niæi. Tri tjedna nakon nastupa bolesti
hemoreolo¹ki je profil bio sliËan onomu u akutnom stadiju. Rezultati ispitivanja pokazali su kako hemoreolo¹ke promjene u
bolesnika s moædanom ishemijom jasno ovise o dobi bolesnika.
KljuËne rijeËi: Cerebrovaskularne bolesti, krv; Cerebrovaskularni inzult, krv; Hemoreologija; Dobni Ëimbenici; Osobe starije dobi
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